Generic Portal

— Research Explorer

Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients

Research output: Contribution to journal › Review article › Academic › peer-review

DOI

https://doi.org/10.3390/pharmaceutics15010163
Final published version

Daan W. Huntjens
Jacob A. Dijkstra
Lisanne N. Verwiel
Mirjam Slijkhuis
Paul Elbers
Matthijs R. A. Welkers
Agnes I. Veldkamp
Marianne A. Kuijvenhoven
David C. de Leeuw
Heshu Abdullah-Koolmees
Maria T. Kuipers
Imke H. Bartelink

Original language	English
Article number	163
Journal	Pharmaceutics
Volume	15
Issue number	1
DOIs	https://doi.org/10.3390/pharmaceutics15010163
Publication status	Published - 1 Jan 2023

Research areas

allogeneic transplantation, antiviral agents, cytomegalovirus, herpesvirus 1, herpesvirus 2, human, immune deficiency, therapeutic drug monitoring

ID: 32159069